New Zealand markets open in 4 hours 20 minutes

Eargo, Inc. (EAR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.57000.0000 (0.00%)
At close: 04:00PM EST

Eargo, Inc.

2665 North First Street
Suite 300
San Jose, CA 95134
United States
650 351 7700

IndustryMedical Devices
Full-time employees243

Key executives

NameTitlePayExercisedYear born
Mr. William H. BrownieInterim CEO & COO625.2kN/A1968
Mr. Daniel ShenCo-Founder and Chief Clinical & Science OfficerN/AN/AN/A
Mr. Mark ThorpeChief Financial OfficerN/AN/A1969
Mr. Tim Trine Ph.D.Chief Technology OfficerN/AN/AN/A
Ms. Christy La PierreChief Legal Officer & SecretaryN/AN/AN/A
Ms. Tricia BurchellSenior Vice President of People OperationsN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.

Corporate governance

Eargo, Inc.’s ISS governance QualityScore as of 1 February 2024 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.